Medical Xpress August 3, 2024
Georgetown University Medical Center

Three high-impact steps could be taken by global health leaders to reshape the global regulatory framework and help address the pressing need for equitable access to diagnostics, therapeutics, and vaccines during public health emergencies, according to a Georgetown global health law expert and a medical student.

In their “Perspective” published today in the New England Journal of Medicine, Georgetown School of Health professor Sam Halabi, JD, and George O’Hara, a Georgetown and David E. Rogers Student Fellow, say these reforms aim to enhance the capacity of national regulatory bodies, particularly in low- and middle-income countries to ensure timely and safe access to essential medical products.

The U.S. Food and Drug Administration (FDA) and a select group of national...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Regulations
ACIP’s Upcoming Meningococcal Recommendations: Added Complexity, Reduced Choice
Federal research cuts could worsen infectious disease toll worldwide, expert warns
What are people asking about COVID-19—and what do doctors wish patients knew?
How Grocery Workers Are Still Bearing The Scars Of Covid-19
Can Flu Shot Nudges Lead to Fewer COVID Vaccinations?

Share This Article